Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
Reel/Frame: | 025957/0503 | |
| Pages: | 6 |
| | Recorded: | 03/11/2011 | | |
Attorney Dkt #: | GENOMIC AND AVENTIS |
Conveyance: | BILL OF SALE AND ASSIGNMENT |
|
Total properties:
3
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
12192825
|
Filing Dt:
|
08/15/2008
|
Publication #:
|
|
Pub Dt:
|
05/14/2009
| | | | |
Title:
|
GENE EXPRESSION MARKERS OF RECURRENCE RISK IN CANCER PATIENTS AFTER CHEMOTHERAPY
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
12464797
|
Filing Dt:
|
05/12/2009
|
Publication #:
|
|
Pub Dt:
|
12/17/2009
| | | | |
Title:
|
TESTS TO PREDICT RESPONSIVENESS OF CANCER PATIENTS TO CHEMOTHERAPY TREATMENT OPTIONS
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
12554783
|
Filing Dt:
|
09/04/2009
|
Publication #:
|
|
Pub Dt:
|
06/17/2010
| | | | |
Title:
|
Method for Determining the Likelihood of Response to HER2 Inhibitors
|
|
Assignees
|
|
|
3711 KENNETT PIKE; SUITE 200 |
GREENVILLE, DELAWARE 19807 |
|
|
|
301 PENOBSCOT DRIVE |
REDWOOD CITY, CALIFORNIA 94063 |
|
Correspondence name and address
|
|
R. BRIAN MCCASLIN
|
|
1041 ROUTE 202-206
|
|
MAIL STOP BW D-303A
|
|
BRIDGEWATER, NJ 08807
|
Search Results as of:
05/29/2024 06:47 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|